Correlation Between Biotechnology Fund and Goldman Sachs
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Goldman Sachs Technology, you can compare the effects of market volatilities on Biotechnology Fund and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Goldman Sachs.
Diversification Opportunities for Biotechnology Fund and Goldman Sachs
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Biotechnology and Goldman is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Goldman Sachs Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Technology and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Technology has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Goldman Sachs go up and down completely randomly.
Pair Corralation between Biotechnology Fund and Goldman Sachs
Assuming the 90 days horizon Biotechnology Fund is expected to generate 1.64 times less return on investment than Goldman Sachs. But when comparing it to its historical volatility, Biotechnology Fund Class is 1.24 times less risky than Goldman Sachs. It trades about 0.06 of its potential returns per unit of risk. Goldman Sachs Technology is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 2,474 in Goldman Sachs Technology on September 3, 2024 and sell it today you would earn a total of 397.00 from holding Goldman Sachs Technology or generate 16.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biotechnology Fund Class vs. Goldman Sachs Technology
Performance |
| Timeline |
| Biotechnology Fund Class |
| Goldman Sachs Technology |
Biotechnology Fund and Goldman Sachs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biotechnology Fund and Goldman Sachs
The main advantage of trading using opposite Biotechnology Fund and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.| Biotechnology Fund vs. Calamos Dynamic Convertible | Biotechnology Fund vs. Dreyfusstandish Global Fixed | Biotechnology Fund vs. Ab Bond Inflation | Biotechnology Fund vs. Limited Term Tax |
| Goldman Sachs vs. Lind Capital Partners | Goldman Sachs vs. Franklin High Yield | Goldman Sachs vs. T Rowe Price | Goldman Sachs vs. T Rowe Price |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |